QuidelOrtho to Report Third Quarter 2025 Financial Results

Rhea-AI Summary

QuidelOrtho (Nasdaq: QDEL) will report its Third Quarter 2025 financial results for the period ended September 28, 2025 after market close on Wednesday, November 5, 2025.

The company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss results, with presentation materials posted to the Events & Presentations section of the investor relations website at the time of the call.

Live access: webcast via https://ir.quidelortho.com; phone dial-in: 833-470-1428 (US) or +1 929-526-1599 (international) using Conference ID 415850. A replay will be available on the investor relations site shortly after the event.

SAN DIEGO, Oct. 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report its financial results for the third quarter 2025 ended September 28, 2025, after the market closes on Wednesday, November 5, 2025.

Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the call from the "Events & Presentations" section of the "Investor Relations" page of the Company's website at https://ir.quidelortho.com. Presentation materials will also be posted to the "Events & Presentations" section of the "Investor Relations" page of the Company's website at the time of the call. Those unable to access the webcast may join the call via phone by dialing 833-470-1428 (domestic) or +1 929-526-1599 (international) and entering Conference ID number 415850.

A replay of the conference call will be available shortly after the event on the "Investor Relations" page of the Company's website under the "Events & Presentations" section.

QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.

About QuidelOrtho Corporation

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com

Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@QuidelOrtho.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-report-third-quarter-2025-financial-results-302591019.html

SOURCE QuidelOrtho Corporation

FAQ

When will QuidelOrtho (QDEL) release its Q3 2025 earnings?

QuidelOrtho will release Q3 2025 results after market close on November 5, 2025 for the period ended September 28, 2025.

What time is the QuidelOrtho (QDEL) earnings conference call on November 5, 2025?

The conference call begins at 2:00 p.m. PT / 5:00 p.m. ET on November 5, 2025.

How can investors listen to QuidelOrtho (QDEL) Q3 2025 earnings webcast?

Access the live webcast and presentation materials via the company's Investor Relations Events & Presentations page at https://ir.quidelortho.com.

What phone numbers and conference ID are used to join the QuidelOrtho (QDEL) call?

Dial 833-470-1428 (domestic) or +1 929-526-1599 (international) and enter Conference ID 415850.

Will a replay of the QuidelOrtho (QDEL) Q3 2025 earnings call be available?

Yes. A replay will be posted shortly after the event on the Investor Relations Events & Presentations page.